The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada

PurposeFluoro-2-deoxyglucose positron-emission tomography (FDG-PET/CT) is now considered a standard investigation for the staging of new cases of stage III NSCLC. However, there is not published level 3 evidence demonstrating the impact of FDG-PET/CT on appropriate therapy in this setting. Using ret...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Craig A. Beers, Gregory R. Pond, James R. Wright, Theodoros Tsakiridis, Gordon S. Okawara, Anand Swaminath
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Subjects:	positron emission tomography PET non-small cell lung cancer NSCLC Ontario Canada
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1210945/full